| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
38,721 |
11,835 |
$1.33M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
7,571 |
3,535 |
$267K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
49,061 |
3,558 |
$230K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
9,099 |
5,896 |
$212K |
| G2024 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source |
8,409 |
1,387 |
$102K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
16,166 |
7,542 |
$61K |
| 87799 |
|
6,490 |
1,789 |
$45K |
| 87900 |
|
1,857 |
1,052 |
$35K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
8,972 |
2,468 |
$31K |
| 87581 |
|
9,441 |
4,464 |
$29K |
| 87486 |
|
9,614 |
4,605 |
$28K |
| 87481 |
|
5,529 |
1,864 |
$21K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,201 |
689 |
$18K |
| 87640 |
|
5,992 |
3,202 |
$17K |
| 87500 |
|
4,733 |
2,699 |
$17K |
| 87653 |
|
4,898 |
2,762 |
$16K |
| 87652 |
|
1,702 |
964 |
$13K |
| 87641 |
|
2,687 |
1,563 |
$12K |
| 87632 |
|
1,609 |
946 |
$12K |
| 87186 |
|
4,560 |
1,859 |
$11K |
| 87631 |
|
409 |
293 |
$8K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,061 |
1,128 |
$5K |
| 87482 |
|
1,543 |
999 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,979 |
1,701 |
$5K |
| 87563 |
|
2,141 |
1,290 |
$3K |
| 87503 |
|
3,517 |
1,142 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
88 |
45 |
$2K |
| 87634 |
|
2,077 |
1,118 |
$1K |
| 87498 |
|
1,685 |
908 |
$1K |
| 87532 |
|
1,683 |
907 |
$1K |
| 87541 |
|
1,686 |
908 |
$1K |
| 87496 |
|
1,685 |
907 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
34 |
31 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
246 |
184 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
246 |
184 |
$1K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
246 |
184 |
$998.42 |
| 87551 |
|
410 |
121 |
$949.82 |
| 87471 |
|
285 |
132 |
$401.55 |
| 87150 |
|
21 |
15 |
$30.95 |